Rhumbline Advisers Rani Therapeutics Holdings, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 312 shares of RANI stock, worth $673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
312
Previous 312
-0.0%
Holding current value
$673
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
41Shares Held
2.96MCall Options Held
32.8KPut Options Held
4.2K-
Vanguard Group Inc Valley Forge, PA710KShares$1.53 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.07 Million2.18% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$968,7420.11% of portfolio
-
United Services Automobile Association San Antonio, TX312KShares$674,1250.03% of portfolio
-
Geode Capital Management, LLC Boston, MA151KShares$325,5850.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $52.9M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...